Monica Capozzi

631 total citations
22 papers, 434 citations indexed

About

Monica Capozzi is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Monica Capozzi has authored 22 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Monica Capozzi's work include Colorectal Cancer Treatments and Studies (8 papers), Neuroendocrine Tumor Research Advances (7 papers) and Neuroblastoma Research and Treatments (5 papers). Monica Capozzi is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Neuroendocrine Tumor Research Advances (7 papers) and Neuroblastoma Research and Treatments (5 papers). Monica Capozzi collaborates with scholars based in Italy, United Kingdom and France. Monica Capozzi's co-authors include Salvatore Tafuto, Alessandro Ottaiano, Chiara De Divitiis, Fabiana Tatangelo, Claudia von Arx, Stefania Scala, Antonio Avallone, Paolo Delrio, Guglielmo Nasti and Alfonso De Stefano and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Monica Capozzi

20 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Capozzi Italy 11 239 133 122 94 72 22 434
María Carmen Riesco Martínez Spain 15 413 1.7× 129 1.0× 116 1.0× 94 1.0× 125 1.7× 42 626
Giulia Rovesti Italy 11 162 0.7× 123 0.9× 70 0.6× 85 0.9× 50 0.7× 27 393
Yiying Guo China 10 257 1.1× 153 1.2× 66 0.5× 30 0.3× 81 1.1× 26 421
Marye J. Boers‐Sonderen Netherlands 14 346 1.4× 194 1.5× 49 0.4× 43 0.5× 114 1.6× 43 523
Viola Baradari Germany 7 202 0.8× 257 1.9× 102 0.8× 77 0.8× 77 1.1× 9 507
Marco Brugia Italy 12 218 0.9× 117 0.9× 27 0.2× 100 1.1× 128 1.8× 31 354
Robert L. De Jager United States 10 405 1.7× 156 1.2× 108 0.9× 112 1.2× 116 1.6× 13 462
Carolina Ortiz Spain 9 218 0.9× 158 1.2× 24 0.2× 88 0.9× 74 1.0× 27 433
Federico Castiglione Italy 8 333 1.4× 100 0.8× 50 0.4× 138 1.5× 142 2.0× 12 465
Chongren Wang China 12 241 1.0× 235 1.8× 47 0.4× 118 1.3× 149 2.1× 24 544

Countries citing papers authored by Monica Capozzi

Since Specialization
Citations

This map shows the geographic impact of Monica Capozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Capozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Capozzi more than expected).

Fields of papers citing papers by Monica Capozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Capozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Capozzi. The network helps show where Monica Capozzi may publish in the future.

Co-authorship network of co-authors of Monica Capozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Capozzi. A scholar is included among the top collaborators of Monica Capozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Capozzi. Monica Capozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buono, Giuseppe, Monica Capozzi, Roberta Caputo, et al.. (2024). CAR-T cell therapy for breast cancer: Current status and future perspective. Cancer Treatment Reviews. 133. 102868–102868. 7 indexed citations
2.
Cocco, Stefania, Alessandra Leone, Michela Piezzo, et al.. (2020). Targeting Autophagy in Breast Cancer. International Journal of Molecular Sciences. 21(21). 7836–7836. 73 indexed citations
3.
Capozzi, Monica, et al.. (2020). A potential prognostic marker in primitive lung neuroendocrine tumor: A case report. The International Journal of Biological Markers. 35(3). 102–106. 1 indexed citations
4.
Cavalcanti, Ernesta, Chiara De Divitiis, Gaetano Corso, et al.. (2020). Implementation of a Hplc Method for the Evaluation of Urinary 4-Hydroxyphenylacetic Acid in Patients with Neuroendocrine Tumors. INFM-OAR (INFN Catania). 1–5.
5.
Ottaiano, Alessandro, Stefania Scala, Nicola Normanno, et al.. (2020). Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients. Applied immunohistochemistry & molecular morphology. 28(10). 755–760. 15 indexed citations
6.
Capozzi, Monica, Chiara De Divitiis, Alessandro Ottaiano, et al.. (2019). <p>Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment</p>. Cancer Management and Research. Volume 11. 3847–3860. 98 indexed citations
7.
Ottaiano, Alessandro, Monica Capozzi, Salvatore Tafuto, et al.. (2019). Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice. Frontiers in Oncology. 9. 766–766. 11 indexed citations
8.
Tafuto, Salvatore, Claudia von Arx, Monica Capozzi, et al.. (2019). Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms. Journal of Clinical Medicine. 8(8). 1224–1224. 10 indexed citations
9.
Arx, Claudia von, Monica Capozzi, Elena López‐Jiménez, et al.. (2019). Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms. Journal of Clinical Medicine. 8(9). 1277–1277. 19 indexed citations
10.
Ottaiano, Alessandro, Antonino Cassata, Monica Capozzi, et al.. (2018). Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?. Frontiers in Oncology. 8. 62–62.
11.
Ottaiano, Alessandro, Alfonso De Stefano, Monica Capozzi, et al.. (2018). First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis. Frontiers in Pharmacology. 9. 441–441. 9 indexed citations
12.
Capozzi, Monica, Chiara De Divitiis, Alessandro Ottaiano, et al.. (2018). Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples. Frontiers in Public Health. 6. 291–291. 3 indexed citations
13.
Ottaiano, Alessandro, Monica Capozzi, Chiara De Divitiis, et al.. (2018). Folfiri-aflibercept vs folfiri-bevacizumab as second line treatment of RAS mutated metastatic colorectal cancer in real practice. Annals of Oncology. 29. viii160–viii160. 1 indexed citations
14.
Ottaiano, Alessandro, Monica Capozzi, Chiara De Divitiis, et al.. (2017). Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples. Anticancer Research. 37(4). 1975–1978. 7 indexed citations
15.
Ottaiano, Alessandro, Maria Napolitano, Monica Capozzi, et al.. (2017). Natural killer cells activity in a metastatic colorectal cancer patient with complete and long lasting response to therapy. World Journal of Clinical Cases. 5(11). 390–390. 8 indexed citations
16.
Ottaiano, Alessandro, Monica Capozzi, Chiara De Divitiis, et al.. (2017). Nab-paclitaxel and gemcitabine in advanced pancreatic cancer: The one-year experience of the National Cancer Institute of Naples.. Journal of Clinical Oncology. 35(4_suppl). 497–497. 3 indexed citations
17.
Ottaiano, Alessandro, Chiara De Divitiis, Monica Capozzi, et al.. (2017). Obesity and Cancer: Biological Links and Treatment Implications. Current Cancer Drug Targets. 18(3). 231–238. 17 indexed citations
18.
Capozzi, Monica, Claudia von Arx, Chiara De Divitiis, et al.. (2016). Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors. Anticancer Research. 36(10). 5025–5030. 25 indexed citations
19.
Ottaiano, Alessandro, Anna Nappi, Salvatore Tafuto, et al.. (2016). Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy. Oncology. 90(1). 36–42. 60 indexed citations
20.
Capozzi, Monica, Caterina Ieranò, Chiara De Divitiis, et al.. (2015). Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it. International Journal of Surgery. 21. S89–S94. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Carmen Riesco Martínez Breakdown of academic impact, for papers by Giulia Rovesti Breakdown of academic impact, for papers by Yiying Guo Breakdown of academic impact, for papers by Marye J. Boers‐Sonderen Breakdown of academic impact, for papers by Viola Baradari Breakdown of academic impact, for papers by Marco Brugia Breakdown of academic impact, for papers by Robert L. De Jager Breakdown of academic impact, for papers by Carolina Ortiz Breakdown of academic impact, for papers by Federico Castiglione Breakdown of academic impact, for papers by Chongren Wang
Rankless by CCL
2026